Assessment of P2Y12 inhibitor usage and switching in acute coronary syndrome patients undergoing percutaneous coronary revascularization-Reference-Cited by-同舟云学术

Assessment of P2Y12 inhibitor usage and switching in acute coronary syndrome patients undergoing percutaneous coronary revascularization

Published:2016-11 Issue: Volume:223 Page:854-859
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Kudaravalli Mrudula,Althouse Andrew D.,Marroquin Oscar C.,Khandhar Sameer J.,Sharbaugh Michael S.,Toma Catalin,Conrad Smith A.J.,Schindler John T.,Lee Joon S.,Mulukutla Suresh R.^ORCID

Funder

Abbott Vascular

St. Jude Medical

UPMC

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N. Engl. J. Med.,2001

2. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Amsterdam;J. Am. Coll. Cardiol.,2014

3. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005

4. Durability of platelet inhibition by clopidogrel;Gurbel;Am. J. Cardiol.,2003

5. Variability in platelet responsiveness to clopidogrel among 544 individuals;Serebruany;J. Am. Coll. Cardiol.,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization Trends In Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor and Cost Among Medicare Beneficiaries;Current Problems in Cardiology;2023-05

2. De-escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: An Updated Meta-analysis and Trial Sequential Analysis of 21 Studies and 38,741 Patients;Journal of Cardiovascular Pharmacology;2022-06

3. The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction;The Korean Journal of Internal Medicine;2022-03-01

4. Short- and Midterm Adherence to Platelet P2Y12 Receptor Inhibitors After Percutaneous Coronary Intervention With Drug-Eluting Stents;Journal of Cardiovascular Pharmacology and Therapeutics;2020-05-18

5. Switching to Clopidogrel in Patients With Acute Coronary Syndrome Managed With Percutaneous Coronary Intervention Initially Treated With Prasugrel or Ticagrelor: Systematic Review and Meta-analysis;Annals of Pharmacotherapy;2019-04-18